Evidence mapPaperPMID 42585165Full record

ArticlePLOS global public health2026

Medication adherence interventions for South Asian populations with cardiovascular disease: A systematic review and narrative synthesis.

Hiranmayi Madabhushi Hari, Anna Robinson-Barella, Andrew Husband

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hiranmayi Madabhushi HariSchool of Pharmacy, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID https://orcid.org/0000-0002-8406-7813
Anna Robinson-BarellaSchool of Pharmacy, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Andrew HusbandSchool of Pharmacy, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID https://orcid.org/0000-0001-8162-8278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

South Asian populations experience a disproportionate burden of cardiovascular disease (CVD) globally, with evidence consistently highlighting suboptimal medication adherence across both regional and diaspora settings. While previous research has primarily identified socio-cultural barriers to adherence, there is a critical need to analyse the effectiveness and feasibility of interventional solutions to improve medication adherence in this population. This systematic review synthesised evidence on the reported effectiveness and feasibility of such interventions from 29 studies published between 2004 and 2025. Data from India, Pakistan, Nepal, Sri Lanka, Bangladesh and diaspora settings (e.g., United Kingdom), were analysed using a narrative synthesis approach. Twenty-six studies reported statistically significant improvements in adherence (p < 0.05). The interventions identified spanned seven themes: behavioural/educational strategies, task-shifting models, mHealth tools, regimen simplification, socio-cultural determinants, measurement of adherence and cultural inclusion practices. The findings highlight a clear 'sustainability gap', where short-term technological or educational bursts often fail to maintain long-term adherence without sustained human interaction or professional follow-up. Furthermore, while pharmacological simplification via polypills, mHealth reinforcement and task-shifting models are effective and feasible, there remains a critical paucity of culturally tailored, faith-sensitive interventions designed to address non-adherence driven by socio-cultural beliefs. Future research must transition toward robust, context-specific socio-cultural adaptation by incorporating objective adherence measures and individualised care models that engage faith-based factors. Ultimately, achieving equitable cardiovascular outcomes in this population requires a multi-level approach that integrates professional reinforcement with scalable technology to ensure long-term sustainability beyond short-term trial effects.

Identifiers

PMID42585165
PMCPMC13465864

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.